Novartis Ag (NVS) Capital Expenditures Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
-36.22% |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
54.04% |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
31.95% |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
12.77% |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
-25.38% |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
73.24% |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
12.50% |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
-22.70% |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
33.46% |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-36.22% |
| Dec 31, 2025 |
-9.14% |
| Sep 30, 2025 |
-10.28% |
| Jun 30, 2025 |
-27.31% |
| Mar 31, 2025 |
-11.89% |
| Dec 31, 2024 |
-37.44% |
| Sep 30, 2024 |
-22.99% |
| Jun 30, 2024 |
-15.56% |
| Mar 31, 2024 |
-35.12% |
| Dec 31, 2023 |
-32.68% |
| Sep 30, 2023 |
-18.10% |
| Jun 30, 2023 |
12.45% |
| Mar 31, 2023 |
34.63% |
| Dec 31, 2022 |
33.48% |
| Sep 30, 2022 |
37.04% |
| Jun 30, 2022 |
19.94% |
| Mar 31, 2022 |
-4.47% |
| Dec 31, 2021 |
11.71% |
| Sep 30, 2021 |
-25.81% |
| Jun 30, 2021 |
-34.87% |
| Mar 31, 2021 |
-3.80% |
| Dec 31, 2020 |
-13.02% |
| Sep 30, 2020 |
21.85% |
| Jun 30, 2020 |
14.70% |
| Mar 31, 2020 |
15.96% |
| Dec 31, 2019 |
-3.83% |
| Sep 30, 2019 |
-21.02% |
| Jun 30, 2019 |
-8.56% |
| Mar 31, 2019 |
-9.30% |
| Dec 31, 2018 |
30.41% |
| Sep 30, 2018 |
22.77% |
| Jun 30, 2018 |
22.59% |
| Mar 31, 2018 |
25.00% |
| Dec 31, 2017 |
-8.87% |
| Sep 30, 2017 |
13.77% |
| Jun 30, 2017 |
25.89% |
| Mar 31, 2017 |
10.65% |
| Dec 31, 2016 |
22.18% |
| Sep 30, 2016 |
23.49% |
| Jun 30, 2016 |
-79,151,843.46% |
| Mar 31, 2016 |
-82,089,452.24% |
| Dec 31, 2015 |
-90,722,791.57% |
| Sep 30, 2015 |
-86,676,546.71% |
| Jun 30, 2015 |
12.11% |
| Mar 31, 2015 |
2.70% |
| Sep 30, 2014 |
11.99% |
| Jun 30, 2014 |
-1.74% |
| Mar 31, 2014 |
3.02% |
| Sep 30, 2013 |
-14.65% |
| Jun 30, 2013 |
-4.80% |
| Mar 31, 2013 |
-20.63% |
| Sep 30, 2012 |
-29.80% |
| Jun 30, 2012 |
-33.33% |
| Mar 31, 2012 |
1.67% |
| Dec 31, 2011 |
-16.64% |
| Sep 30, 2011 |
-47.40% |
| Jun 30, 2011 |
-27.61% |
| Mar 31, 2011 |
-37.83% |
| Dec 31, 2010 |
-8.72% |
| Sep 30, 2010 |
16.63% |
| Jun 30, 2010 |
26.80% |
| Mar 31, 2010 |
17.39% |
